Arcellx (ACLX) Receivables - Accured (2022 - 2025)
Arcellx (ACLX) recorded quarterly Receivables - Accured of $3.6 million in Q4 2025, down 12.2% quarter-over-quarter from $4.1 million in Q3 2025, and up 44.0% on a YoY basis from $2.5 million in Q4 2024.
Arcellx (ACLX) Receivables - Accured (2022 - 2025) Analysis & Trends
Arcellx's Receivables - Accured history runs 4 years deep, the most recent figure standing at $3.6 million for Q4 2025.
- In Q4 2025, Receivables - Accured rose 44.0% year-over-year to $3.6 million; the TTM figure through Dec 2025 stood at $3.6 million (up 44.0% YoY), while the FY2025 annual figure was $3.6 million, up 44.0% from the prior year.
- Receivables - Accured was $3.6 million for Q4 2025 at Arcellx, down from $4.1 million in the prior quarter.
- In the past five years, Receivables - Accured ranged from a high of $4.1 million in Q3 2025 to a low of $500000.0 in Q4 2022.
- Historically, Receivables - Accured has averaged $2.5 million across 4 years, with a median of $2.9 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Receivables - Accured soared 210.0% in 2024, then dropped 6.45% in 2025.
- A 4-year view of Receivables - Accured shows it stood at $500000.0 in 2022, then surged by 180.0% to $1.4 million in 2023, then jumped by 78.57% to $2.5 million in 2024, then surged by 44.0% to $3.6 million in 2025.
- The last three Receivables - Accured figures came in at $3.6 million (Q4 2025), $4.1 million (Q3 2025), and $3.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acc. Int. Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 3.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.60 Mn |
| Dec 31, 2025 | 3.60 Mn |
| Sep 30, 2025 | 4.10 Mn |
| Sep 30, 2025 | 4.10 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Mar 31, 2025 | 2.90 Mn |
| Mar 31, 2025 | 2.90 Mn |
| Dec 31, 2024 | 2.50 Mn |
| Dec 31, 2024 | 2.50 Mn |
| Sep 30, 2024 | 3.40 Mn |
| Sep 30, 2024 | 3.40 Mn |
| Jun 30, 2024 | 3.20 Mn |
| Jun 30, 2024 | 3.20 Mn |
| Mar 31, 2024 | 3.10 Mn |
| Mar 31, 2024 | 3.10 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Sep 30, 2023 | 1.68 Mn |
| Sep 30, 2023 | 1.68 Mn |